Viewing Study NCT00649532


Ignite Creation Date: 2025-12-24 @ 9:48 PM
Ignite Modification Date: 2026-01-01 @ 2:06 AM
Study NCT ID: NCT00649532
Status: COMPLETED
Last Update Posted: 2024-04-24
First Post: 2008-03-30
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Fasting Study of Ondansetron Tablets 24 mg and ZofranĀ® Tablets 24 mg
Sponsor: Mylan Pharmaceuticals Inc
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module